Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.460
+0.080 (3.36%)
At close: Jun 26, 2026, 4:00 PM EDT
2.550
+0.090 (3.66%)
After-hours: Jun 26, 2026, 5:57 PM EDT
Lipocine Market Cap
Lipocine has a market cap or net worth of $20.28 million as of June 26, 2026. Its market cap has increased by 14.58% in one year.
Market Cap
20.28M
Enterprise Value
-4.45M
1-Year Change
14.58%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $20.28M, a decrease of -75.36%. That is a compound annual growth rate of -10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 20.30M | -54.48% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 22.14M |
| Marker Therapeutics | 21.84M |
| VYNE Therapeutics | 21.74M |
| Polyrizon | 21.38M |
| Allarity Therapeutics | 20.21M |
| Cellectar Biosciences | 19.74M |
| Palatin Technologies | 19.66M |
| Celularity | 19.26M |